Figure 14.
AKT3 promotes LX-2 migration and activation. (a and b) The migration ability of each group of cells transfected with AKT3-siRNA or pcDNA3.1-AKT3 was tested by Transwell assays (a; scale bars = 200 μm) and wound healing assays (b; scale bars = 500 μm). (c to e) COL1A1 and α-SMA expressions were examined by qRT–PCR (c) and Western blot (d and e) in LX-2 transfected with AKT3-siRNA. (f to h) COL1A1 and α-SMA expressions were examined by qRT–PCR (f) and Western blot (g and h) in LX-2 transfected with pcDNA 3.1-AKT3. (A color version of this figure is available in the online journal.)
